Diarrhea NewsNews on Diarrhea continually updated from thousands of sources around the net.Salix Initiates Phase 3 For Rifaximin In Non-Constipation Irritable Bowel Syndrome- July 3, 2008 Salix Pharmaceuticals, Ltd. announced that the Company has initiated patient enrollment in TARGET 1 and TARGET 2, its Phase 3, randomized, double-blind, placebo-controlled, multicenter studies to assess the ...http://www.topix.net/health/diarrhea/2008/07/salix-initiates-phase-3-for-rifaximin-in-non-... |